To observe the functions of miR-301a-3p on the progression of SLE, the miR-301a-3p inhibitors were transfected into PBMCs of the patients, and ELISA assay was performed to evaluate the expression levels of IL-6, INF-γ, and IL-17A. Here, IL6 is linked to systemic lupus erythematosus.